The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Protara Therapeutics Inc shares valued at $63,800 were purchased by Levy Richard S on May 14 ’25. At $3.19 per share, Levy Richard S acquired 20,000 shares. The insider’s holdings grew to 51,000 shares worth approximately $0.22 million following the completion of this transaction.
Also, Zummo Jacqueline sold 21,224 shares, netting a total of over 96,145 in proceeds. Following the sale of shares at $4.53 each, the insider now holds 98,861 shares.
Before that, Zummo Jacqueline had added 21,224 shares to its account. In a trade valued at $96,569, the Officer bought Protara Therapeutics Inc shares for $4.55 each.
As published in their initiating research note from Scotiabank on April 16, 2025, Protara Therapeutics Inc [TARA] has been a Sector outperform and the price target has been revised to $12. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid March. Earlier on June 04, 2021, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for TARA stock.
Analyzing TARA Stock Performance
On last trading session, Protara Therapeutics Inc [NASDAQ: TARA] rose 1.38% to $4.41. The stock’s lowest price that day was $4.28, but it reached a high of $4.5 in the same session. During the last five days, there has been a surge of approximately 8.09%. Over the course of the year, Protara Therapeutics Inc shares have jumped approximately 133.33%. Shares of the company reached a 52-week high of $6.20 on 01/06/25 and a 52-week low of $2.77 on 07/02/25.
Support And Resistance Levels for Protara Therapeutics Inc (TARA)
According to the 24-hour chart, there is a support level at 4.29, which, if violated, would cause prices to drop to 4.18. In the upper region, resistance lies at 4.51. The next price resistance is at 4.62. RSI (Relative Strength Index) is 76.34 on the 14-day chart, showing overbought technical sentiment.
Is Protara Therapeutics Inc subject to short interest?
Stocks of Protara Therapeutics Inc saw a sharp steep in short interest on 2025-09-15 dropping by 81739.0 shares to 2.69 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 2.77 million shares. A decline of -3.04% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 17.99 of the overall float, the days-to-cover ratio (short ratio) decline to 17.99.
Which companies own the most shares of Protara Therapeutics Inc (TARA)?
In terms of Protara Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 12 in the next 12 months, up nearly 175.86% from the previous closing price of $4.35. Analysts anticipate Protara Therapeutics Inc stock to reach 12 by 2025, with the lowest price target being 12. In spite of this, 1 analysts ranked Protara Therapeutics Inc stock as Buy at the end of 2025. On February 17, 2021, Oppenheimer assigned a price target of “an Outperform” to the stock and initiated coverage with a $43.
